Trial intelligence / Profile preview

Co-trimoxazole vs Azithromycin for Undifferentiated Fever in Nepal

NCT02773407Phase 3Completed

Sponsor
Oxford University Clinical Research Unit
Start
May 2016
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of trimethoprim + sulfamethoxazole in Undifferentiated febrile illness (AUFI), sponsored by Oxford University Clinical Research Unit. Started May 2016; status: completed.

02

Drugs

trimethoprim + sulfamethoxazole
03

Conditions

Undifferentiated febrile illness (AUFI)

Beyond the preview

Go deeper on NCT02773407.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02773407.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call